ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Alkido Pharma Inc

Alkido Pharma Inc (AIKI)

3.56
0.00
( 0.00% )
Updated: 20:00:00

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
3.56
Bid
3.53
Ask
3.98
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
3.56
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
5,345,000
Dividend Yield
-
PE Ratio
-0.38
Earnings Per Share (EPS)
-4.28
Revenue
2.04M
Net Profit
-22.88M

About Alkido Pharma Inc

AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin... AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing a antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. Show more

Sector
Security Brokers & Dealers
Industry
Security Brokers & Dealers
Headquarters
Wilmington, Delaware, USA
Founded
-

AIKI Latest News

Dominari Securities CEO, Kyle Wool, Discusses the IPO Market on "The Claman Countdown"

Dominari Securities CEO, Kyle Wool, Discusses the IPO Market on "The Claman Countdown" PR Newswire NEW YORK, June 21, 2023 NEW YORK, June 21, 2023 /PRNewswire/ -- Dominari Holdingsย Inc...

Dominari Holdings Appoints George Way Chief Financial Officer

Dominari Holdings Appoints George Way Chief Financial Officer PR Newswire NEW YORK, April 3, 2023 Experienced Finance Executive to Support Growth Strategyย  NEW YORK, April 3, 2023 /PRNewswire/...

Dominari Holdings Provides Update on Share Repurchase Program

Dominari Holdings Provides Update on Share Repurchase Program PR Newswire NEW YORK, Feb. 24, 2023 NEW YORK, Feb. 24, 2023 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the...

Dominari Holdings Provides Update on Share Repurchase Program

Dominari Holdings Provides Update on Share Repurchase Program PR Newswire NEW YORK, Dec. 28, 2022 NEW YORK, Dec. 28, 2022 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the...

AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH)

AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH) PR Newswire NEW YORK, Dec. 22, 2022 NEW YORK, Dec. 22, 2022 /PRNewswire/ --ย AIkido Pharma...

AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes

AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes PR Newswire NEW YORK, Nov. 28, 2022 Leading Advanced Materials Company Now Listed on NASDAQ under the symbol, ASPI NEW...

AIkido Share Repurchase Continues

AIkido Share Repurchase Continues PR Newswire NEW YORK, Oct. 6, 2022 NEW YORK, Oct. 6, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update...

AIkido Purchases More Shares

AIkido Purchases More Shares PR Newswire NEW YORK, Oct. 5, 2022 NEW YORK, Oct. 5, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company") today provided an update on...

Share Repurchase Program Continues

Share Repurchase Program Continues PR Newswire NEW YORK, Oct. 4, 2022 NEW YORK, Oct. 4, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update...

AIkido Pharma Continues Share Repurchase Program

AIkido Pharma Continues Share Repurchase Program PR Newswire NEW YORK, Oct. 3, 2022 NEW YORK, Oct. 3, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 1.68
(190.16%)
79.1M
TGLTreasure Global Inc
$ 1.2899
(89.61%)
82.76M
NVVENuvve Holding Corporation
$ 6.11
(55.87%)
24.29M
UXINUxin Ltd
$ 2.1225
(33.91%)
1.9M
OCTOEightco Holdings Inc
$ 3.25
(27.45%)
181.45k
ELABElevai Labs Inc
$ 0.1088
(-61.14%)
8.63M
FRGTFreight Technologies Inc
$ 0.0792
(-30.40%)
15.2M
ZJYLJin Medical International Ltd
$ 2.845
(-30.27%)
484.24k
ADTXAditxt Inc
$ 0.27462
(-28.22%)
1.11M
PRFXPainReform Ltd
$ 0.597501
(-22.51%)
246.9k
XPONExpion360 Inc
$ 0.1015
(19.69%)
270.86M
TGLTreasure Global Inc
$ 1.2899
(89.61%)
82.76M
KAVLKaival Brands Innovations Group Inc
$ 1.68
(190.16%)
79.1M
INTCIntel Corporation
$ 22.61
(3.53%)
71.21M
NVDANVIDIA Corporation
$ 115.9592
(-0.04%)
59.32M

AIKI Discussion

View Posts
Viewmont Viewmont 2 years ago
Got it thanks!
๐Ÿ‘๏ธ0
Viewmont Viewmont 2 years ago
Hi, I haven't been following AIKI for a while, just noticed its not trading, checked TDA / google with no result, did the ticker change or not public anymore after company bought shares? Thanks!
๐Ÿ‘๏ธ0
db101 db101 2 years ago
More insider shares purchased todayโ€ฆ
๐Ÿ‘๏ธ0
db101 db101 2 years ago
More insider shares purchasedโ€ฆ
๐Ÿ‘๏ธ0
db101 db101 2 years ago
AIKI looks to be headed back to 7โ€ฆ
๐Ÿ‘๏ธ0
db101 db101 2 years ago
More insider shares purchasedโ€ฆ
๐Ÿ‘๏ธ0
db101 db101 2 years ago
A positive weekโ€ฆ up 3.11%
๐Ÿ‘๏ธ0
db101 db101 2 years ago
โ€ฆmore shares purchased by the CEO
๐Ÿ‘๏ธ0
db101 db101 2 years ago
โ€ฆAIKI seems to be getting its legs
๐Ÿ‘๏ธ0
db101 db101 2 years ago
AIKI is undervaluedโ€ฆ
๐Ÿ‘๏ธ0
db101 db101 2 years ago
AIKI is readyโ€ฆ
๐Ÿ‘๏ธ0
db101 db101 2 years ago
The Company reported that on October 5, 2022, the Company purchased 10,500 shares of common stock at $7.0679 per share.
๐Ÿ‘๏ธ0
db101 db101 2 years ago
The Company reported that on October 4, 2022, the Company purchased 38,035 shares of common stock at $6.99 per share. Anthony Hayes, CEO of AIkido stated, "We believe the Company stock continues to be undervalued and we are using this opportunity to enhance shareholder value by reducing the amount of stock that is outstanding."
๐Ÿ‘๏ธ0
db101 db101 2 years ago
AIKI is buying more sharesโ€ฆ 45k
๐Ÿ‘๏ธ0
ANTI-BAGHOLDER ANTI-BAGHOLDER 2 years ago
Shalom Auerbach board member on AMRR doesnโ€™t mess around.



Shalom Auerbach, a significant stockholder of AIkido Pharma Inc. (NASDAQ: AIKI) beneficially owning approximately 3.4% of its common stock, today issued the following letter to members of the AIkido Pharma Inc. Board of Directors:

https://www.streetinsider.com/dr/news.php?id=20187179&gfv=1
๐Ÿ‘๏ธ0
PStockPickz PStockPickz 3 years ago
https://www.prnewswire.com/news-releases/aikido-pharma-secures-interest-in-electric-truck-maker-tevva-motors-ltd-301386841.html
๐Ÿ‘๏ธ0
PStockPickz PStockPickz 3 years ago
Averaging in some .48s
๐Ÿ‘๏ธ0
PStockPickz PStockPickz 3 years ago
Snagging some 50s
๐Ÿ‘๏ธ0
RNsidersbuying RNsidersbuying 3 years ago
AIkido Pharma announces $3M share repurchase program

https://ih.advfn.com/stock-market/NASDAQ/alkido-pharma-AIKI/stock-news/87087386/aikido-pharma-announces-3m-share-repurchase-progr
๐Ÿ‘๏ธ0
urge2surge urge2surge 3 years ago
Classic dog pile here. I'm out and won't be back.
๐Ÿ‘๏ธ0
RNsidersbuying RNsidersbuying 3 years ago
AIKI .47 - So, outsiders have sold this company's stock down to less than .50-on-the-dollar and insiders aren't filing Form-4-Buys by the truckload? How can management EVER promote it's own stock again when they show no interest in less than .50-on-the-dollar?

And what would be management's risk be in buying here at less than .50-on-the-dollar? It goes down to .25-on-the-dollar...whoa-is-me
๐Ÿ‘๏ธ0
urge2surge urge2surge 3 years ago
One of the worst companies I've invested in. Finally dumped it for big loss. I obviously played the fool again. Glta
๐Ÿ‘๏ธ0
georgie18 georgie18 3 years ago
AIKI...72...:partying_face:
๐Ÿ‘๏ธ0
db101 db101 3 years ago
Get ready for the buttered popcorn...
๐Ÿ‘๏ธ0
georgie18 georgie18 3 years ago
AIKI...73...Bullish 3 Gap Downs Reversal Pattern to the Upside on this Oversold Chart...

Psar flipped Bullish...Been accumulating under $1...

Chart https://schrts.co/exhPMSRA ...
๐Ÿ‘๏ธ0
White Lightning White Lightning 3 years ago
Looks like good news AlKl

https://apple.news/AnumIdrGsR-CRYxMFTxj-5Q

This should go over a dollar soon here!!!!
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 3 years ago
AIkido owns 525,000 shares of DatChat, which it previously purchased for $500,000.00. As of September 13th, DatChat shares closed at $6.54, well higher than its IPO price and representing a more than 600% return or an additional $3,433,500.00 added to AIKI balance sheet. $AIKI

AIkido owns 525,000 shares of DatChat, which it previously purchased for $500,000.00. As of September 13th, DatChat shares closed at $6.54, well higher than its IPO price and representing a more than 600% return or an additional $3,433,500.00 added to AIKI balance sheet. $AIKI— Tommy Coops (@ohheytommy) October 12, 2021
๐Ÿ‘๏ธ0
georgie18 georgie18 3 years ago
AIKI...92...on the P/M Gappa...:partying_face:
๐Ÿ‘๏ธ0
urge2surge urge2surge 3 years ago
Impressed with the CEO management taking investment stakes in pivotal companies, thereby adding significant value here. Great job IMO.
๐Ÿ‘๏ธ0
TGOO TGOO 3 years ago
Interesting, low ss here...
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 3 years ago
Very volatile but looks ready
๐Ÿ‘๏ธ0
sportd sportd 3 years ago
Added letโ€™s see what this can do
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 3 years ago
Kaboom!
๐Ÿ‘๏ธ0
Sirpeter Sirpeter 3 years ago
Bullish
๐Ÿ‘๏ธ0
antman antman 3 years ago
Would be nice... it has been ages since they did the financing around $1.65 and it began to drop ever since
๐Ÿ‘๏ธ0
db101 db101 3 years ago
AIkido Pharma Releases Shareholder Update; Near Term Catalysts Approaching
๐Ÿ‘๏ธ0
db101 db101 3 years ago
News...
๐Ÿ‘๏ธ0
georgie18 georgie18 3 years ago
AIKI...86...Tue, July 27, 2021, 10:00 AM
AIkido's License to Technology Includes Targeted Psilocybin Treatment for Cancer Patients

NEW YORK, July 27, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for application No.: 16/477,125. This technology relates to the use of novel and proprietary central nervous system (CNS) homing peptides. This technology has been exclusively sublicensed to AIkido Pharma for use of psilocybin for the therapeutic treatment of neuroinflammatory disease in cancer patients.
๐Ÿ‘๏ธ0
georgie18 georgie18 3 years ago
AIKI...97...Bounce off the .85 range on the Bullish Engulfing Reversal Candle to the Upside...

Psar flipped to a Bullish Buy Position...as the MACD Crossed to the positive side...

Chart...https://schrts.co/FqVVQIHY ...
๐Ÿ‘๏ธ0
wesley_ wesley_ 3 years ago
$1.10 nice
๐Ÿ‘๏ธ0
urge2surge urge2surge 3 years ago
No respect from the street on this company. Corporate..how about getting some dignity and respect by actually executing and aggressive communications to the investing arena? Grow a pair..
๐Ÿ‘๏ธ0
urge2surge urge2surge 3 years ago
Yeah definitely under substantial book value here. Not just on cash, but potential pipeline, nols, licensing rev's. You buy the dips here and wait on a significant return.
๐Ÿ‘๏ธ0
Chess Master Chess Master 3 years ago
BULLISH RESEARCH ARTICLE! Trading under cash and great upside on great results. https://insiderfinancial.com/akido-pharmas-aiki-clinical-trial-results-continues-to-validates-gileads-21-billion-purchase-of-immunomedics/181580/
๐Ÿ‘๏ธ0
ClayTrader ClayTrader 3 years ago
* * $AIKI Video Chart 04-21-2021 * *

Link to Video - click here to watch the technical chart video

๐Ÿ‘๏ธ0
georgie18 georgie18 3 years ago
AIKI...86...NEW YORK, April 16, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today noted that a recent study announced positive early results from a PSMA 617-Lu177 study conducted by a leading global pharmaceutical company. The report provides strong indications for analogous success in similar technology the Company is helping to develop.

The article can be accessed at:
https://www.thepharmaletter.com/article/further-vindication-for-novartis-in-radioligand-space
๐Ÿ‘๏ธ0
georgie18 georgie18 3 years ago
AIKI...$1.20...in the P/M...NEW YORK, April 7, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that it has been granted an exclusive sublicense to technology related to the use of novel and proprietary central nervous system (CNS) homing peptides for the therapeutic treatment of neuroinflammatory disease in cancer patients...

https://www.otcmarkets.com/stock/AIKI/news/story?e&id=1857821
๐Ÿ‘๏ธ0
georgie18 georgie18 3 years ago
AIKI...$1.17...Bidding the Lower Band to the 20ma to add to my Core Position...

Looking for the 2 Open Gaps to fill and a $2 Breakout..imo...we shall see....

Chart...https://schrts.co/BrjKBXYy ...
๐Ÿ‘๏ธ0
georgie18 georgie18 3 years ago
AIKI...$1.17...in the P/M...https://www.otcmarkets.com/stock/AIKI/news/story?e&id=1849940 ...:party:
๐Ÿ‘๏ธ0
Taurus69 Taurus69 3 years ago
$aiki $1.17 ? 0.0 (0.00%)
Volume: 3,920,435 @03/26/21 7:41:58 PM EDT
๐Ÿ‘๏ธ0
ClayTrader ClayTrader 4 years ago
* * $AIKI Video Chart 03-24-2021 * *

Link to Video - click here to watch the technical chart video

๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock